These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6205328)

  • 1. [Arterial hypertension induced by an excess of mineralocorticoids caused by abuse of nasal spray. Report of a case].
    De Venuto G; Mattarei M; Dal Piaz A; De Santa A; Torboli PL; Miori R
    Minerva Med; 1984 Jun; 75(27):1673-77. PubMed ID: 6205328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The etiology of a syndrome of factitious mineralocorticoid excess: a steroid-containing nasal spray.
    Funder JW; Adam WR; Mantero F; Kraft N; Ulick S
    J Clin Endocrinol Metab; 1979 Dec; 49(6):842-6. PubMed ID: 92477
    [No Abstract]   [Full Text] [Related]  

  • 3. [Excess mineralocorticoid syndrome secondary to nasal sprays containing 9 alpha-fluoroprednisolone].
    Foresti V; Parisio E; Ricci G
    Minerva Med; 1987 Sep; 78(17):1305-11. PubMed ID: 2444906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exogenous hypermineralocorticism caused by a nasal spray containing 9-alpha fluoroprednisolone].
    Virgolini L; Geatti O; Giunta G
    Minerva Cardioangiol; 1984; 32(7-8):473-5. PubMed ID: 6208510
    [No Abstract]   [Full Text] [Related]  

  • 5. [Collateral effects of 9-alpha-fluor-prednisolone acetate and kanamycin, administered by nasal spray. Clinical experience and experimental data].
    Petrini MT; Perpignano G; Iannelli S; Petrini L; Maccioni A; Bogliolo A; Pintus M; Puxeddu P
    Minerva Med; 1987 Jun; 78(11):777-84. PubMed ID: 2438595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypokalemic myopathy in arterial hypertension].
    Santeusanio F; Nunzi E; Natali P; Nicoletti I; Angeletti G; Filipponi P; Rambotti P
    Minerva Med; 1982 Sep; 73(35):2279-86. PubMed ID: 7110606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe arterial hypertension caused by chronical abuse of a topical mineralocorticoid.
    Armbruster H; Vetter W; Reck G; Beckerhoff R; Siegenthaler W
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):170-3. PubMed ID: 51837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone.
    Mantero F; Armanini D; Opocher G; Fallo F; Sampieri L; Cuspidi B; Ambrosi C; Faglia G
    Am J Med; 1981 Sep; 71(3):352-7. PubMed ID: 6169277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypertension and hypokalemia caused by a nasal spray containing fluorprednisolone acetate].
    Maiorano G; Loiacono N; Di Bello V; Contursi V; Castelnuovo F; Albano O
    Boll Soc Ital Cardiol; 1981; 26(5):465-71. PubMed ID: 7340877
    [No Abstract]   [Full Text] [Related]  

  • 10. [Arterial hypertension with hypopotassemia and hypochloremic metabolic alkalosis caused by abuse of a nasal spray].
    Pepe M; Altomonte L; Palumbo P; Zoli A; Mangia A
    Minerva Med; 1983 Oct; 74(39):2323-6. PubMed ID: 6197683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Again on the subject of arterial hypertension caused by the chronic cutaneous application of mineralocorticoids].
    Bisignani G; Boncompagni F; Plastina F
    Minerva Endocrinol; 1988; 13(1):16. PubMed ID: 3367885
    [No Abstract]   [Full Text] [Related]  

  • 12. Factitious hypertension with mineralocorticoid excess in an infant.
    De Stefano P; Bongo IG; Borgna-Pignatti C; Severi F
    Helv Paediatr Acta; 1983 May; 38(2):185-9. PubMed ID: 6874387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypokalemic myopathy caused by fluoroprednisolone in a nasal spray. Observations 2 cases].
    Cantello R; Bergamini L; Delsedime M; Durelli L; Troni W; Gilli M; Cocito D
    Minerva Med; 1983 Jun; 74(25):1463-7. PubMed ID: 6856155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual cause of factitious mineralocorticoid excess.
    Vanderijst JF; Vandeleene B; De Plaen JF; Kolanowski J
    Acta Clin Belg; 1992; 47(6):408-13. PubMed ID: 1283935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypokalemic myopathy associated with intranasal steroid use (factitious mineralocorticoid excess syndrome.
    Cantello R; Bergamini L; Delsedime M; Durelli L; Troni W; Gilli M; Cocito D; Bisbocci D
    J Neurol; 1982; 226(4):265-8. PubMed ID: 6174707
    [No Abstract]   [Full Text] [Related]  

  • 16. [Iatrogenic pseudohyperaldosteronism: clinical polymorphism].
    Parazzi F; Pesce D; Bartolini P; Pizzorno L; De Michelis A
    Minerva Endocrinol; 1985; 10(2):125-8. PubMed ID: 2415807
    [No Abstract]   [Full Text] [Related]  

  • 17. [Arterial hypertension and hyporeninemic hypoaldosteronism. Description of a clinical case].
    Torboli P; Spagnolli W; Contu C; Ramponi C; Marzano A; Fedrizzi A; Miori R
    Minerva Med; 1991 Mar; 82(3):147-50. PubMed ID: 2006035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray.
    Vita G; Bartolone S; Santoro M; Toscano A; Carrozza G; Girlanda P; Frisina N
    Clin Neuropathol; 1987; 6(2):80-5. PubMed ID: 3594977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autometrically and automatically monitored, iatrogenous, inhalant-decongestant-associated high blood pressure quantified by rhythmometry.
    Scarpelli PT; Scarpelli L; Livi R; Groppi E; Cornélissen G; Romano S; Cagnoni M; Halberg F
    Prog Clin Biol Res; 1987; 227B():183-200. PubMed ID: 2442774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhabdomyolysis, oedema and arterial hypertension: different syndromes related to topical use of 9-alpha-fluoroprednisolone.
    Lauzurica R; Bonal J; Bonet J; Romero R; Teixido J; Serra A; Caralps A
    J Hum Hypertens; 1988 Oct; 2(3):183-6. PubMed ID: 3236321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.